| Molecular formula | C46H56N12O6 |
|---|
| Molecular weight | 873 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 4345065 |
|---|
What GHRP-6 is
GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of approximately 873 g/mol (PubChem CID 4345065). It has no FDA-approved label, no approved brand name, and no established indication for use in humans. GHRP-6 is classified here as an unapproved research compound, meaning any use outside of a formal research setting falls outside regulatory oversight.
Trial footprint
Public clinical trial registries show no registered trials for GHRP-6 at this time. The absence of registered trials means there is no clinical trial evidence available to summarize regarding safety or effects in humans.
FAQ
No. GHRP-6 has no FDA-approved label, no approved brand name, and no approved medical indication. It is classified as an unapproved research compound.
Public registries currently show no registered clinical trials for GHRP-6. This means there is no clinical trial data available on its effects or safety in humans.
GHRP-6 is a synthetic peptide with the molecular formula C46H56N12O6 and a molecular weight of about 873 g/mol, cataloged under PubChem CID 4345065.
No adverse event report data is currently available for GHRP-6, so no pattern of reported side effects can be summarized at this time.
It means the substance has not gone through FDA review for safety or effectiveness and has no approved medical use. Any use occurs outside standard regulatory oversight.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-11-07